Abstract
Reformulation of anti-tuberculosis drugs into dry powder particles for inhalation is a novel strategy that aims to increase therapeutically relevant drug concentration at the primary site of infection and to limit associated toxicity by avoiding or minimizing first-pass metabolism. Development of such formulations ultimately requires quantified evidence of the deposition, absorption and clearance of inhaled active ingredient. In this context, we investigated the potential of radiolabelling particles with 153Sm for subsequent gamma imaging, and to demonstrate that the technique is not detrimental to particle integrity. The study showed that the known properties of spray dried leucine (a major constituent of an inhalable capreomycin formulation) for deep lung inhalation are not altered by incorporation of samarium-chloride (SmCl3) at 10% (w/w), or by neutron activation of particles that include stable 152SmCl3. SEM imaging indicated that the particle morphology was homogeneous and spherical after neutron activation. No discoloration of the samples or a change in dry powder particle size at 5 minutes occurred, provided the optimized formulations were activated for only 1 minute. Activation for 1 minute still provides enough 153Sm for imaging purposes.
Keywords: Gamma imaging, 153Sm radiolabel, spray dried powder particles, pulmonary drug delivery, tuberculosis, leucine, capreomycin, human immunodeficiency virus (HIV), multi-drug resistance, Neutron Activation, Chemical, Reagents, chromatography (HPLC), Samarium Formulation, homogeneous.
Drug Delivery Letters
Title:Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin
Volume: 2 Issue: 3
Author(s): Lindie Venter, Judith Wagener, P. Bernard Fourie and Jan Rijn Zeevaart
Affiliation:
Keywords: Gamma imaging, 153Sm radiolabel, spray dried powder particles, pulmonary drug delivery, tuberculosis, leucine, capreomycin, human immunodeficiency virus (HIV), multi-drug resistance, Neutron Activation, Chemical, Reagents, chromatography (HPLC), Samarium Formulation, homogeneous.
Abstract: Reformulation of anti-tuberculosis drugs into dry powder particles for inhalation is a novel strategy that aims to increase therapeutically relevant drug concentration at the primary site of infection and to limit associated toxicity by avoiding or minimizing first-pass metabolism. Development of such formulations ultimately requires quantified evidence of the deposition, absorption and clearance of inhaled active ingredient. In this context, we investigated the potential of radiolabelling particles with 153Sm for subsequent gamma imaging, and to demonstrate that the technique is not detrimental to particle integrity. The study showed that the known properties of spray dried leucine (a major constituent of an inhalable capreomycin formulation) for deep lung inhalation are not altered by incorporation of samarium-chloride (SmCl3) at 10% (w/w), or by neutron activation of particles that include stable 152SmCl3. SEM imaging indicated that the particle morphology was homogeneous and spherical after neutron activation. No discoloration of the samples or a change in dry powder particle size at 5 minutes occurred, provided the optimized formulations were activated for only 1 minute. Activation for 1 minute still provides enough 153Sm for imaging purposes.
Export Options
About this article
Cite this article as:
Venter Lindie, Wagener Judith, Bernard Fourie P. and Rijn Zeevaart Jan, Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin, Drug Delivery Letters 2012; 2 (3) . https://dx.doi.org/10.2174/2210304x11202030155
DOI https://dx.doi.org/10.2174/2210304x11202030155 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Current Protein & Peptide Science Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Cannabinoids and Schizophrenia: Therapeutic Prospects
Current Pharmaceutical Design Mouse Models of Autoimmune Uveitis
Current Pharmaceutical Design The Application of Optical Technology in Microfluidic Systems
Current Proteomics Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis
Current Pharmacogenomics and Personalized Medicine Flexibility in the Molecular Design of Acetylcholinesterase Reactivators: Probing Representative Conformations by Chemometric Techniques and Docking/QM Calculations
Letters in Drug Design & Discovery Induction of Cytochromes P450
Current Drug Metabolism Increased Expression of Forkhead Box Protein 3 Gene of Regulatory T Cells in Patients with Active Tuberculosis
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Cancer: The Challenges and Successes of Structure-Based Drug Design Against the Human Purinome
Current Topics in Medicinal Chemistry Hodgkin Lymphoma in HIV Positive Patients
Current HIV Research XDR-TB, What is it; How is it Treated; and why is Therapeutic Failure so High?
Recent Patents on Anti-Infective Drug Discovery Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry
Current Topics in Medicinal Chemistry Recent Highlights on the Synthesis of Pyrazoles with Antimicrobial Activity
Current Bioactive Compounds Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds Fragment-Based Drug Discovery and Molecular Docking in Drug Design
Current Pharmaceutical Biotechnology Repurposing Drugs to Combat Drug Resistance in Leprosy: A Review of Opportunities
Combinatorial Chemistry & High Throughput Screening Metal-Based Antimicrobial Protease Inhibitors
Current Medicinal Chemistry Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Discriminating Drug-Like Compounds by Partition Trees with Quantum Similarity Indices and Graph Invariants
Current Pharmaceutical Design